Gillian – Interview 03
Gillian was diagnosed with CIN 3 in 2006, aged 27. She had a cone biopsy and would have liked more information before and during treatment.
Gillian had a couple of smear tests in Ireland and then moved to England in 2002. She didn’t attend regularly for cervical screening but, in 2006, when she went to see her GP for holiday vaccinations, she was also given a smear test. She;d had no symptoms but results showed abnormalities.
At this point, Gillian had never heard of CIN or colposcopy. She felt that her appointment at the colposcopy clinic was rushed. She was treated by cone biopsy under local anaesthetic but reacted to the anaesthetic – her body went into shock and started shaking. Gillian found the procedure painful and said she bled heavily afterwards for about a month. Because she was concerned, she went to Accident and Emergency, where she was treated but continued to bleed.
During her Christmas holidays, Gillian went back to Ireland to visit her family. There she made an appointment to see a doctor privately because she and her family were so concerned. She and her doctor wanted more information about her diagnosis and treatment so contacted her hospital in England. The information they received confirmed that she;d had CIN 2 and CIN 3 and that she;d had a cone biopsy.
Gillian felt that she had not been given enough information about the treatment she had been given. She would have liked more information before and during treatment, about treatment options and having children after treatment for CIN 3.
It took about one and a half years before Gillian stopped bleeding between periods after the initial treatment. She had follow-up appointments every six months to begin with. After having two clear smear tests, she went onto annual screening and will now have yearly follow-up for ten years. She continues to be seen by her doctor in Ireland for these appointments.
Gillian encourages other women to go for cervical screening and would like cervical screening in England to start before the age of 25.